Faces of ALS: Creating Memories

Kristin Rankin, PhD, of Palos Park, was a happily married mom to three energetic young daughters and on track to make tenure at the University of Illinois at Chicago’s School of Public Health. But everything changed when she was diagnosed, …

One-Year Anniversary of FDA-approved ALS Treatment Radicava

This May marks the one-year anniversary of the FDA-approval of Radicava, the only FDA-approved ALS treatment option in the last 20 years. Radicava’s developer, Mitsubishi Tanabe Pharma Corporation (MTPC) began researching ALS in 2001 through an interactive clinical platform that …

2 Teams, 1 Goal

Grayslake Lacrosse vs ALS There is nothing like celebrating when a community comes together for a shared vision. On Friday, May 11th, the Grayslake North High School and Grayslake Central High School lacrosse teams are holding their first annual Grayslake …

May is ALS Awareness Month

What are you doing to raise awareness? May isn’t just an exciting month because we can finally put away our winter jackets. May is also exciting because it’s ALS Awareness Month, a chance for the ALS community to work together …

Kiskinis lab work published in journal Cell Stem Cell

We are excited to share a newly published finding from Dr. Evangelos Kiskinis, one of the lead researchers at the Les Turner ALS Center at Northwestern Medicine. A few words from Dr. Kiskinis: “In our latest manuscript, which was published …

Machine learning: Calculating disease

“Machine learning might identify patients earlier, predict their outcomes better, and assign them more efficiently to appropriate clinical trials.” Read the full article highlighting machine learning in relation to ALS, on the Nature International Journal of Science, here.